These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20679854)

  • 1. Role of propranolol in the management of periocular hemangiomas.
    Mishra A; Holmes WJM; Gorst C; Liew SH
    Plast Reconstr Surg; 2010 Aug; 126(2):671. PubMed ID: 20679854
    [No Abstract]   [Full Text] [Related]  

  • 2. Atenolol: a promising alternative to propranolol for the treatment of hemangiomas.
    Raphaël MF; de Graaf M; Breugem CC; Pasmans SGMA; Breur JMPJ
    J Am Acad Dermatol; 2011 Aug; 65(2):420-421. PubMed ID: 21763565
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemangioma update: pearls from 30 years of treatment.
    Zide BM; Levine SM
    Ann Plast Surg; 2012 Jul; 69(1):99-103. PubMed ID: 21734553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Propranolol therapy to treat problematic hemangiomas : a new standard therapy makes its debut].
    Löffler H; Kosel C; Cremer H; Kachel W
    Hautarzt; 2009 Dec; 60(12):1013-6. PubMed ID: 19859669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of propranolol for treatment of hemangiomas in PHACE syndrome.
    Solomon T; Ninnis J; Deming D; Merritt TA; Hopper A
    J Perinatol; 2011 Nov; 31(11):739-41. PubMed ID: 22037156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Topical timolol in the treatment of periocular superficial infantile hemangiomas: a prospective study].
    Ye XX; Jin YB; Lin XX; Ma G; Chen XD; Qiu YJ; Chen H; Hu XJ
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2012 May; 28(3):161-4. PubMed ID: 22870699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Propranolol in infantile hemangiomas].
    Léauté-Labrèze C
    Arch Pediatr; 2015 Apr; 22(4):452-5. PubMed ID: 25753275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propranolol response in patients with segmental versus focal facial hemangiomas: A retrospective case-control study.
    Schmid F; Hoeger PH
    J Am Acad Dermatol; 2022 Aug; 87(2):490-491. PubMed ID: 34752824
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical Outcomes of Infants With Periorbital Hemangiomas Treated With Oral Propranolol.
    Xue L; Sun C; Xu DP; Liu ZM; Wang XK
    J Oral Maxillofac Surg; 2016 Nov; 74(11):2193-2199. PubMed ID: 27235180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atenolol treatment for severe infantile hemangiomas: comparison with a propranolol group of our centre.
    Dakoutrou M; Alexopoulos A; Miligkos M; Georgiadou E; Kanaka-Gantenbein C; Kakourou T
    J Eur Acad Dermatol Venereol; 2019 May; 33(5):e199-e200. PubMed ID: 30707776
    [No Abstract]   [Full Text] [Related]  

  • 11. Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants.
    de Graaf M; Breur JMPJ; Raphaël MF; Vos M; Breugem CC; Pasmans SGMA
    J Am Acad Dermatol; 2011 Aug; 65(2):320-327. PubMed ID: 21601311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of β-Adrenergic Receptor Subtypes in Proliferative, Involuted, and Propranolol-Responsive Infantile Hemangiomas.
    Phillips JD; Zhang H; Wei T; Richter GT
    JAMA Facial Plast Surg; 2017 Mar; 19(2):102-107. PubMed ID: 27737446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas.
    Kim LHC; Hogeling M; Wargon O; Jiwane A; Adams S
    J Pediatr Surg; 2011 Apr; 46(4):759-763. PubMed ID: 21496551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of complicated facial hemangiomas with Beta-blocker (propranolol) therapy.
    Mishra A; Holmes W; Gorst C; Liew S
    Plast Reconstr Surg; 2011 Apr; 127(4):1742-1743. PubMed ID: 21460687
    [No Abstract]   [Full Text] [Related]  

  • 15. Intralesional steroids in cutaneous hemangioma.
    Reyes BA; Vazquez-Botet M; Capo H
    J Dermatol Surg Oncol; 1989 Aug; 15(8):828-32. PubMed ID: 2754087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of complicated facial hemangiomas with beta-blocker (propranolol) therapy.
    Arneja JS; Pappas PN; Shwayder TA; Cullen ML; Becker CJ; Hamzavi FH; Roarty JD; Madgy DN; Baker JD
    Plast Reconstr Surg; 2010 Sep; 126(3):889-895. PubMed ID: 20811222
    [No Abstract]   [Full Text] [Related]  

  • 17. Saving PHACE.
    Tavella SK; Ng YT
    Pediatr Neurol; 2018 Aug; 85():82-83. PubMed ID: 29937379
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of propanolol for treatment of large infantile haemangiomas-a report of two cases and review of the literature.
    Chandran S; Ari D; Jose J
    Ann Acad Med Singap; 2013 May; 42(5):253-6. PubMed ID: 23771115
    [No Abstract]   [Full Text] [Related]  

  • 19. Late rebound of infantile hemangioma after cessation of oral propranolol.
    Shehata N; Powell J; Dubois J; Hatami A; Rousseau E; Ondrejchak S; McCuaig C
    Pediatr Dermatol; 2013; 30(5):587-91. PubMed ID: 24016283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large Doses of Propranolol for the Treatment of Infantile Cephalic and Facial Hemangiomas: A Clinical Report of 38 Cases.
    Jianguo K; Xichun W; Mingkun Z; Qiaoling C; Wenjin L
    J Clin Pediatr Dent; 2015; 39(3):268-71. PubMed ID: 26208073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.